Mesothelioma deaths and diagnoses continue to rise in the United States despite regulation limiting the use of asbestos, according to a study published online June 11 in JCO Global Oncology. Kyle ...
Three studies show benefits in adults inadequately controlled with diet and exercise, receiving metformin, using basal insulin ...
The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.
A wearable ultrasound patch can provide continuous, real-time information about blood flow in the fetus and umbilical cord, according to a study published online May 26 in Nature Biotechnology. Geonho ...
A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.
Gray matter volume increased by true acupoint, with increases in specific areas positively correlated with motor recovery ...
The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...
A single, once-weekly tablet could change HIV treatment landscape; weight loss drug orforglipron efficacy assessed at all stages of menopause; hemophilia ...
The FDA linked 12 severe kidney complications to alli between 2007 and 2023, resulting in 8 hospitalizations and 5 patients requiring dialysis. The Food and Drug Administration (FDA) has updated the ...
A new extended maintenance regimen for Ebglyss has been approved for eligible patients with moderate to severe atopic dermatitis.
Data show that orforglipron, a once-daily oral GLP-1 receptor agonist, drives significant, long-term weight reduction in women with obesity or overweight across all 3 stages of menopause: premenopause ...
Phase 3 ISLEND-1 and ISLEND-2 trials met primary endpoints at week 48, showing a novel, once-weekly oral single-tablet regimen is noninferior to daily B/F/TAF or standard ART.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results